Skip to main content
OpenTrials

Clinical trial condition

Rectal Diseases

Explore clinical trials studying Rectal Diseases. Study availability and eligibility vary by location and protocol.

5,958 public trials 1,252 recruiting studies
Refine in advanced search Browse all conditions

Rectal Diseases trial results

Active, Not Recruiting

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

NCT02298959

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +60 more
Locations
  • Moffitt Cancer Center-International Plaza Tampa, Florida, United States
  • Moffitt Cancer Center - McKinley Campus Tampa, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
View Trial Details
Active, Not Recruiting

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

NCT03485209

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +28 more
Locations
  • UCSD Medical Center - Encinitas Encinitas, California, United States
  • UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion) La Jolla, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UCSD Koman Family Outpatient Pavilion La Jolla, California, United States
View all 175 locations
View Trial Details
Active, Not Recruiting

ABCSG C08-Exercise II: Trial of Endurance Exercise Following Adjuvant Chemotherapy for Colorectal Cancer

NCT03822572

Conditions
Colonic Diseases, Colorectal Carcinoma, Colorectal Neoplasms, +9 more
Locations
  • LKH Salzburg-PMU, UNiv. KLinik f. Innere Med III Salzburg, State of Salzburg, Austria
  • Med. Univ. Graz Graz, Styria, Austria
  • BKH Kufstein Kufstein, Tyrol, Austria
  • KH St. Josef Braunau Braunau am Inn, Upper Austria, Austria
View Trial Details
Active, Not Recruiting

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

NCT06447662

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +29 more
Locations
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
  • Highlands Oncology Group, PA Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

NCT06607185

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +53 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
View all 45 locations
View Trial Details
Active, Not Recruiting

Physically Active During Cancer Treatment (FAKT)

NCT03885817

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +15 more
Locations
  • Ålesund sjukehus Ålesund, Norway
  • Sørlandet sykehus, Kristiansand Kristiansand, Norway
  • Levanger sykehus Levanger, Norway
  • Ullevål Oslo, Norway
View Trial Details
Active, Not Recruiting

Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer

NCT05425940

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Exelixis Clinical Site #65 Jonesboro, Alabama, United States
  • Exelixis Clinical Site #30 Phoenix, Arizona, United States
  • Exelixis Clinical Site #70 Tucson, Arizona, United States
  • Exelixis Clinical Site #9 Duarte, California, United States
View all 133 locations
View Trial Details

Related conditions